| 1YC5 | A:30-75,A:117-165 | SIR2-P53 PEPTIDE-NICOTINAMIDE |
| 2H2D | A:30-75,A:117-165 | THE STRUCTURAL BASIS FOR SIRTUIN SUBSTRATE AFFINITY |
| 2H2F | A:30-75,A:117-165 | THE STRUCTURAL BASIS FOR SIRTUIN SUBSTRATE AFFINITY |
| 2H2G | A:30-75,A:117-165 | THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE AFFINITY |
| 2H2H | A:30-75,A:117-165 | THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE SPECIFICITY |
| 2H2I | A:30-75,A:117-165 | THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE AFFINITY |
| 2H4F | A:30-75,A:117-165 | SIR2-P53 PEPTIDE-NAD+ |
| 2H4H | A:30-75,A:117-165 | SIR2 H116Y MUTANT-P53 PEPTIDE-NAD |
| 2H4J | A:30-75,A:117-165 | SIR2-DEACETYLATED PEPTIDE (FROM ENZYMATIC TURNOVER IN CRYSTAL) |
| 2H59 | A:30-75,A:117-165; B:30-75,B:117-165 | SIR2 H116A-DEACETYLATED P53 PEPTIDE-3'-O-ACETYL ADP RIBOSE |
| 3D4B | A:30-75,A:117-165 | CRYSTAL STRUCTURE OF SIR2TM IN COMPLEX WITH ACETYL P53 PEPTIDE AND DADME-NAD+ |
| 3D81 | A:30-75,A:117-165 | SIR2-S-ALKYLAMIDATE COMPLEX CRYSTAL STRUCTURE |
| 3JR3 | A:30-75,A:117-165 | SIR2 BOUND TO ACETYLATED PEPTIDE |
)
)